Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
about
CIViC databasemTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenibHyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells.BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin?BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.Values of molecular markers in the differential diagnosis of thyroid abnormalities.Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing.BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers.
P2860
Q27612411-C262EFA8-11F4-421E-AA7D-F074C9BFAE62Q36545458-9F463E33-6B43-4765-BAA9-999EDCB291A8Q36962376-6CC3FFE2-5426-4C59-97C8-CD4402FFEEFBQ37448258-AC94FDC2-30D3-40C1-A56B-5FF96587C267Q38569221-240832BC-527F-4E98-A173-719B6F66C807Q38865611-949CB5AA-B3E9-4718-8BAE-A6B089EFA979Q39051174-F0A1F715-98FE-4C63-9077-21F56799CDDAQ53534519-AFAC867B-6169-4F30-BC94-5F73FF268D31Q53705974-6285F8BF-A3D2-42EF-8E7B-FB963732DCCE
P2860
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
@ast
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
@en
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.
@nl
type
label
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
@ast
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
@en
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.
@nl
altLabel
Extended Antitumor Responseof aBRAFV600E Papillary Thyroid Carcinoma to Vemurafenib
@en
prefLabel
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
@ast
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
@en
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.
@nl
P2093
P2860
P356
P1476
Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
@en
P2093
Doron Lipson
Gary A Palmer
Jeffrey S Ross
Jeffrey Sharman
Joseph Fiorillo
Phil J Stephens
Siraj M Ali
Vincent A Miller
Wade Carson
P2860
P356
10.1159/000363377
P577
2014-05-01T00:00:00Z